MSG Research & Consulting

Permanently closed
3356 Sherman Ct Ste 103
Saint Paul, MN 55121

MSG Research & Consulting is a professional services firm based in Saint Paul, MN, specializing in market research and strategic consulting for a diverse range of industries. The company offers tailored solutions to help clients make informed decisions and drive business growth.

With a team of experienced analysts and consultants, MSG Research & Consulting provides comprehensive research services, data analysis, and strategic recommendations to support clients in achieving their business objectives. The firm is committed to delivering high-quality insights and actionable strategies to meet the unique needs of each client.

Generated from their business information

Own this business?
See a problem?

You might also like

CVRx, Inc

ABOUT CVRx Company Overview CVRx is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is well financed and supported by an outstanding board of directors. They have established a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. Hypertension affects over 73 million people in the United States and is estimated to cause 1 in every 8 deaths worldwide1 It is a major risk factor for cardiovascular disease, morbidity and mortality. It is a costly disease and yearly costs to treat hypertension in the United States are estimated to be $69.4 billion1 Twenty-five percent of people with hypertension cannot adequately control their hypertension with medications and lifestyle modifications 2, 3 It is a disease that needs new treatment solutions. Heart failure affects over 5 million people in the United States and is associated with a high risk of dying, with a five-year mortality rate of 74%.4, 5 It has a severe impact on quality of life with symptoms including: general fatigue and weakness; shortness of breath and swelling in the legs and ankles. It is also a costly disease, with an estimated direct and indirect costs of $37.2 billion annually in the United States.6 There are no proven treatments available today that improve the function of the heart in individuals with heart failure caused by heart filling problems, also called diastolic heart failure. Diastolic heart failure accounts for up to 50% of heart failure cases.7
United StatesMinnesotaSaint PaulMSG Research & Consulting

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.